CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 55 filers reported holding CASI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $133,000 | +329.0% | 45,064 | +121.5% | 0.00% | – |
| Q3 2020 | $31,000 | -65.9% | 20,343 | -44.7% | 0.00% | – |
| Q2 2020 | $91,000 | +16.7% | 36,806 | -3.9% | 0.00% | – |
| Q1 2020 | $78,000 | -27.8% | 38,297 | +10.0% | 0.00% | – |
| Q4 2019 | $108,000 | -13.6% | 34,803 | -8.0% | 0.00% | – |
| Q3 2019 | $125,000 | +3.3% | 37,827 | 0.0% | 0.00% | – |
| Q2 2019 | $121,000 | +18.6% | 37,827 | +5.5% | 0.00% | – |
| Q1 2019 | $102,000 | -20.3% | 35,867 | +12.3% | 0.00% | – |
| Q4 2018 | $128,000 | -22.4% | 31,943 | -9.3% | 0.00% | – |
| Q3 2018 | $165,000 | -50.6% | 35,227 | -13.3% | 0.00% | – |
| Q2 2018 | $334,000 | +2936.4% | 40,614 | +1389.9% | 0.00% | – |
| Q1 2018 | $11,000 | +22.2% | 2,726 | -5.1% | 0.00% | – |
| Q4 2017 | $9,000 | +800.0% | 2,871 | +251.8% | 0.00% | – |
| Q3 2014 | $1,000 | – | 816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 951,064 | $7,827,000 | 4.06% |
| Wellington Shields Capital Management, LLC | 855,056 | $7,037,000 | 1.16% |
| Manatuck Hill Partners, LLC | 15,090 | $124,000 | 0.05% |
| Moors & Cabot, Inc. | 22,935 | $187,000 | 0.02% |
| Perceptive Advisors | 43,682 | $360,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 120,000 | $988,000 | 0.01% |
| ALPS ADVISORS INC | 125,015 | $1,029,000 | 0.01% |
| MetLife Investment Management, LLC | 26,316 | $217,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 136,518 | $1,124,000 | 0.00% |
| Private Advisor Group, LLC | 15,001 | $122,000 | 0.00% |